Fangli Chen

Dr. Fangli Chen is a partner in Proskauer's Litigation Department and chair of the Life Sciences Patent Practice. She is a distinguished IP lawyer known for her strategic foresight and exceptional problem-solving skills. Fangli represents a diverse range of biotech and pharmaceutical companies, seamlessly integrating her team with her clients' in-house operations to ensure a deep understanding of their business and proactively anticipating their needs. Her sharp legal and business instincts and collaborative approach enable her to provide swift, effective solutions that safeguard her clients' intellectual property rights and optimize success, while saving her clients valuable time and resources.

Fangli effectively identifies and transforms technological developments into valuable intellectual property assets, specializing in the strategic development of complex IP portfolios for companies that align with their business objectives.

Fangli’s practice also focuses on post-grant review before the USPTO, pre-litigation and litigation strategy, due diligence investigations, freedom-to-operate, non-infringement and invalidity analysis, licensing and other IP matters in connection with commercial transactions.

Fangli also has a wealth of experience in the following areas:

IP Diligence: advising companies and investors in evaluating intellectual property assets, assessing FTO risks and providing thoughtful and pragmatic advice aligned with business goals.

IP Landscape analysis: conducting complex IP landscape analysis and identify white space.

Post-grant challenges: representing clients in inter partes review interference and various foreign opposition proceedings.

Technology transactions & licensing: advising clients on matters relating to technology or material transfer, licensing and research collaborations.